Closantel

This classification denotes an antihelminthic agent with the molecular formula C22H14Cl2I2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EUL532EI54, chemically known as 5-chloro-alpha(sup 4)-(p-chlorophenyl)-alpha(sup 4)-cyano-3,5-diiodo-2,4-salicyloxylidide but generally known as closantel, which bears US NIH Compound Identifier 42574. European Medicines Agency schedules Closantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06769MIG. The term CLOSANTEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). CLOSANTEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule closantel under HS 29269095 and SITC 51484. As of Q4 2014, CLOSANTEL remains the US FDA Preferred Term for this commodity. Closantel bears US NLM identifiers UMLS ID C0055944 and NCI Concept Code C79920. SMILES: IC1C(O)C(C(=O)NC2C(CC(C(C3CCC(CL)CC3)C#N)C(CL)C2)C)CC(I)C1.